Ekocorp

Ekocorp Net Margin

The Net Profit Margin of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is -35.46 %. In the previous year, Net Profit Margin was -23.37 % — a change of 51.72% (lower).

Net Margin

-35.46 %

YoY

51.72%

Last updated:

Net Profit Margin of Ekocorp is 2020 -35.46 % . Net Profit Margin of Ekocorp was 2019 -23.37 % . It decreases by 51.72% lower compared to the previous year.

For Ekocorp, the net margin of -35.5% is down versus 5.9% a few years ago.

The Ekocorp Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2015
10.72 NGN
Jan 1, 2016
5.89 NGN
Jan 1, 2017
-81.59 NGN
Jan 1, 2018
-22.30 NGN
Jan 1, 2019
-23.37 NGN
Jan 1, 2020
-35.46 NGN
The Ekocorp Net Margin history
YEARNet MarginYoY
-35.46 %+51.72%
-23.37 %+4.78%
-22.30 %-72.67%
-81.59 %-1,486.20%
5.89 %-45.08%
10.72 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

Net Profit Margin of Ekocorp is -35.46 % in 2020.

Net Profit Margin of Ekocorp changed from -23.37 % to -35.46 %, representing a 51.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Ekocorp since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Ekocorp with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Ekocorp

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Ekocorp